Jacobio Pharma Reports Data from the P-II Study of Glecirasib for Treating Non-Small Cell Lung Cancer
Shots: Jacobio highlighted the data from the P-II registrational trial evaluating...
Veru Reports First Patient Enrollment in the P-IIb Study of Enobosarm Plus Semaglutide for High Quality Weight Loss
Shots: The P-IIb study assesses the safety & efficacy of enobosarm (3mg, 6mg)...
Vistagen Reports Positive Results from P-IIa Study of PH15 for Improvement of Psychomotor Impairment
Shots: Vistagen reports P-IIa study (n=10) results, PH15 (1.6µg) shown stati...
Atom Bioscience Initiates Enrolment in Global P-IIb/III Study of ABP-671 to Treat Chronic Gout in US
Shots: Atom Bioscience initiated patient enrolment in the US for a
